Debate: How and when will the telemedicine surge reach mental healthcare?

Covid-19 Pan­dem­ic Dri­ves Patients—and Deal Makers—to Telemed­i­cine (The Wall Street Jour­nal): The coro­n­avirus pan­dem­ic has put the once-niche cat­e­go­ry of telemed­i­cine in the spot­light and is now dri­ving a flur­ry of deal activ­i­ty involv­ing vir­tu­al health-care providers … Patients have embraced vir­tu­al care as a way to stay in touch with doc­tors for urgent care or…

Read More

Four guidelines for smart use of smartphones

These days, you can’t go any­where with­out hear­ing about how tech­nol­o­gy is ruin­ing every­thing, includ­ing our hap­pi­ness. There is some truth to this, but it’s not the whole sto­ry. Tech­nol­o­gy can be bad for us—for exam­ple, when social media gives us FOMO (fear of miss­ing out) or traps us in fil­ter bub­bles that pre­vent us from…

Read More

The Good, the Bad and the Ugly of Applied Neuroscience and Neurotechnology

After a very busy month, it’s time now for Sharp­Brains e‑newsletter to sum­ma­rize the lat­est ini­tia­tives, tools and ideas for life­long brain health and men­tal fit­ness — and to share a few puz­zles and illu­sions to tease your brain. ? A grow­ing num­ber of class­rooms in Chi­na are equipped with arti­­fi­­cial-intel­li­­gence cam­eras and brain-wave track­ers. Video:…

Read More

Update: Trained older brains can outperform untrained younger ones at demanding cognitive tasks

_______________ Time for Sharp­Brains e‑newsletter, fea­tur­ing the lat­est research, tools and think­ing for life­long brain health and men­tal well-being — and a cou­ple fun brain teasers :-) New brain research: Can trained old­er brains out­per­form untrained younger ones at demand­ing cog­ni­tive tasks? Quick answer: YES Sep­tem­ber 17th @ UC Berke­ley: Dis­rupt­ing neu­rode­gen­er­a­tive dis­eases New neu­rotech and…

Read More

Can digital Cognitive Behavioral Therapy (CBTi) become the universal first-line treatment for insomnia?

__________ Pear Ther­a­peu­tics’ dig­i­tal insom­nia ther­a­peu­tic will put FDA’s Pre­Cert frame­work through its paces (Mobi­Health­News): “Pre­scrip­tion dig­i­tal ther­a­peu­tics com­pa­ny Pear Ther­a­peu­tics announced late last week that it has filed an FDA mar­ket­ing autho­riza­tion for Som­ryst, its dig­i­tal cog­ni­tive behav­ioral ther­a­py for the treat­ment of adults with chron­ic insom­nia and depres­sion. While an approval from the…

Read More